SaveHealth reports on eczema medications, detailing various options from topical treatments to advanced therapies for ...

Pimecrolimus and tacrolimus, 2 topical calcineurin inhibitors for the treatment of atopic dermatitis (AD), were not shown to increase the risk of cancer based on moderate-certainty evidence from a ...

Few issues in immunosuppression are as controversial as the use of the calcineurin inhibitors (CNIs), cyclosporine (CsA) and tacrolimus (TAC). Although the short-term benefits of these agents are ...

Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — Researchers showed with moderate certainty that topical calcineurin inhibitors did not ...

The panel examines the evolution of atopic dermatitis (AD) treatment beyond topical steroids and calcineurin inhibitors, while evaluating the safety and efficacy of a specific topical therapy in AD ...

A review published in JAAD discussed the off-label use of systemic tacrolimus and voclosporin in patients with various dermatologic conditions. Tacrolimus is approximately 100 times more potent than ...

Credit: Getty Images In a meta-analysis of 16 randomized clinical trials, calcineurin inhibitors showed better efficacy than standard of care lupus nephritis induction over the short term. Calcineurin ...

June 2, 2008 (Toronto) — A postoperative regimen that avoids long-term use of calcineurin inhibitors (CNIs) in renal transplant patients improves kidney function at 1 year, according to results of the ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY): U.S. Food and Drug Administration Approves Orencia® (abatacept) in Combination with a Calcineurin Inhibitor and Methotrexate for the ...